This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1997 Jun 14;349(9067):1710-1.

doi: 10.1016/S0140-6736(97)22024-6.

Anti-oxidant therapy for ischaemic heart disease: where do we stand?

N Stephens¹

Affiliations

PMID: 9193375
DOI: 10.1016/S0140-6736(97)22024-6

Comment

Anti-oxidant therapy for ischaemic heart disease: where do we stand?

N Stephens. Lancet. 1997.

. 1997 Jun 14;349(9067):1710-1.

doi: 10.1016/S0140-6736(97)22024-6.

Author

N Stephens¹

Affiliation

¹ Department of Cardiology, Northwick Park Hospital, Harrow, UK.

PMID: 9193375
DOI: 10.1016/S0140-6736(97)22024-6

No abstract available

PubMed Disclaimer

Comment in

Antioxidants and ischaemic heart disease.
Shahar E. Shahar E. Lancet. 1997 Aug 30;350(9078):667; author reply 668. doi: 10.1016/S0140-6736(05)63362-4. Lancet. 1997. PMID: 9288073 No abstract available.

Comment on

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.
Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP. Rapola JM, et al. Lancet. 1997 Jun 14;349(9067):1715-20. doi: 10.1016/S0140-6736(97)01234-8. Lancet. 1997. PMID: 9193380 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information